Direct Peptide Reactivity Assay

Topic: Skin sensitisation

Test Method Number:
TM2009-06 (EU)
Short Name of TM:
DPRA
Year received:
2009
Responsible Organisation:
Protocol(s)/SOP(s):
154
General Comments:
Validation finalised, ECVAM Recommendation published, OECD TG available

Method Description

The DPRA supports the discrimination between sensitising and non-sensitising chemicals. It measures in chemico the binding of test chemicals to model synthetic peptides containing either lysine or cysteine.

Within the skin sensitization Adverse Outcome Pathway the covalent binding of electrophilic chemicals with nucleophilic sites of amino acids in skin proteins is postulated to be the molecular initiating event (MIE) (i.e. key event 1 – protein binding reactions) leading to skin sensitisation.

In skin proteins many amino acids contain electron-rich groups capable of reacting with sensitisers. Lysine and cysteine are those most often quoted but others such as arginine, histidine, methionine and tyrosine can react with electrophilic chemicals.

Track Approval Status

  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
Step
Submission Show status
Validation Show status
Peer-review Show status
Recommendation Show status
Regulatory acceptance/Standards Show status